Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
Sebastien Lobet, PhD at Saint-Luc University Clinics Cliniques, Co-founder of Activlim-Hemo, shared on LinkedIn:
”I had the honor of being invited to the Nordic Baltic Haemophilia Nurse and Physiotherapy Meeting, held over the past two days in Oslo.
I presented the ACTIVLIM-Hemo scale, a tool to assess activity limitations in adults with haemophilia, developed using a robust Rasch-based methodology.
The scale is unidimensional, linear, and reproducible, providing a reliable measure of functional performance.
ACTIVLIM-Hemo has been translated into 11 languages, with 5 already available.
It is freely accessible to all clinicians wishing to evaluate their patients’ activity limitations.
Developed by Prof. Massimo Penta (Arsalis and UCLouvain) and the Haematology Department of the Saint-Luc University Clinics Cliniques.
References:
Lobet S et al., Haemophilia, 2024. DOI: 10.1111/hae.14954
Lobet S et al., Haemophilia, 2023. DOI: 10.1111/hae.14705”
Stay updated with Hemostasis Today.
-
May 29, 2026, 04:37Josefin Ahnström: How Andexanet Alfa Impacts TFPIα Function
-
May 29, 2026, 03:19Building Safer Systems for Anticoagulation Management – ISTH
-
May 29, 2026, 03:07Early Diagnosis Can Change the Lives of Women With Haemophilia – EHC
-
May 29, 2026, 02:41Ifeanyichukwu Ifechidere: The Biggest DOAC Myth in Coagulation – ‘No Monitoring Required’
-
May 29, 2026, 02:35Mariam Swidan: Why Is LDH the ‘Tattletale’ of the Lab?
-
May 29, 2026, 02:20Yuntian Wang: Multi-View Learning for Predicting Avatrombopag Response in Pediatric Immune Thrombocytopenia
-
May 29, 2026, 01:57Giuseppina Caligiuri: Pathophysiological Challenges and Emerging Therapeutic Strategies in Acute Stroke
-
May 28, 2026, 23:47Hussnain Javaid: The Importance of Targeted Examination in Iron Deficiency Anaemia
-
May 28, 2026, 23:47ASH Heads to ASCO26 with Career Opportunities and Global Hematology Leadership